Drug Type Small molecule drug |
Synonyms BMS-341 |
Target |
Action modulators |
Mechanism GR modulators(Glucocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC33H34FN5O5S |
InChIKeyBMILECFASGFOOO-VWLOTQADSA-N |
CAS Registry1772705-31-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arthritis | Preclinical | United States | 28 May 2015 |





